REFERENCES
- Reilly J, Compagnon A, Tournier P, Bastin R, DuSuit H. Les accidents du traitement des fievres typhoides par la chloromycetine. Annales de Medecine (Paris) 1950; 51: 597–629.
- Abernathy RS, Spink WW. Studies with brucella endotoxin in humans: significance of susceptibility to endotoxin in the pathogenesis of brucellosis. J Clin Investig 1958; 37: 219–231.
- Berkowitz FE, Vallabh P, Altman DI, Diamantes F, VanWyk HJP, Stroucken LMM. Jarisch-Herxheimer reaction in meningococcal meningitis. Am J Dis Child 1983; 137: 599.
- Hopkin DA. Too-rapid destruction of gramnegative organisms. Lancet 1977; 2: 603–604.
- Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DF. Serial quantitation of endotoxemia and bacteremia during therapy for gramnegative bacterial sepsis. J Infect Dis 1988; 157: 565–568.
- Hurley JC. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis 1992; 15: 840–854.
- Prins JM, van Deventer SJH, Kuijper EJ, Speelman R. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994; 38: 1211–1218.
- Prins JM, van Agtmael MA, Kuijper EJ, Sander JH, van Deventer SJH, Speelman P. Antibiotic-induced endotoxin release in patients with gram-negative sepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886–891.
- Dofferhoff ASM, Nijland JH, de Vries-Hospers HG, Mulder POM, Weits J, Bom VJJ. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: An in-vitro and in-vivo study. Scand J Infect Dis 1991; 23: 745–754.
- Schiro DD, Aldridge KE. Broth micro-dilution suscepti-bility testing of anaerobic bacteria. In: Isenbery HD, ed. Clinical Microbiology Procedure Handbook, Washington D.C., American Society for Microbiology Publication, 1992: 5.55-6.17.
- Walterspiel JW, Kaplan SL, Mason EO. Protective effect of sub-inhibitory polymyxin B alone and in combination with ampicillin for overwhelming Haemophilus influenzae type b infection in infant rat: evidence for in vivo and in vitro release of free endotoxin after ampicillin treatment. Paediatr Res 1986; 20: 237–241.
- Crosby HA, Sion JF, Penn CW, Elliott TSJ. Antibiotic-induced release of endotoxin from bacteria in vitro. J Med Microbiol 1994; 40: 23–30.
- Simon DM, Koeing G, Trenholme GM. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J Infect Dis 1991; 164: 800–802.
- Arditi M, Kabut W, Yogev R. Antibiotic-induced bacter-ial killing stimulates tumor necrosis factor-g release in whole blood. J Infect Dis 1993; 167: 240–244.
- Shenep JL, Barton RP, Mogan KA. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis 1985; 151: 1012–1018.
- Anderson BM, Solberg O. Release of endotoxin from Neisseria meningitidis: a short survey with a preliminary report on virulence in mice. Natl Inst Public Health Ann 1980; 3: 49–55.
- Anderson BM, Solberg O. The endotoxin liberating effect of antibiotics on meningococcus in vitro. Acta Pathol Mirocrobiol Scand, 1980; 88: 231–236.
- Russel PRB. Free endotoxin: a review. Microbios Lett 1979; 2: 125–135.
- Marston A, Bulkley GB, Fiddian-Green RG, Haglund UH, eds, Splanchnic ischaemia and multiple organ failure. London, Edward Arnold, 1989.
- Olofsson P, Nylander G, Olsson P. Endotoxin routes of transport in experimental peritonitis. Am J Surg 1986; 151: 443–336.
- Bayston KF, Cohen J. Bacterial endotoxin and current concepts in the diagnosis and treatment of endotoxaemia. J Med Microbiol 1990; 31: 73–83.